Startups selected for Illumina's genomics incubator in China

By The Science Advisory Board staff writers

November 19, 2021 -- Illumina and investment firm Sequoia Capital China have selected the first two startups to join the Sequoia Capital China Intelligent Healthcare Genomics Incubator located in Zhangjiang Cell Industrial Park, Shanghai.

The incubator serves as a company creation engine focused on supporting life sciences startups that are poised to deliver breakthrough applications in genomics and multiomics, Illumina said.

The startups selected for the inaugural funding cycle include:

  • Mobidrop Biotechnology, a medical device and research tools company developing cutting-edge, single-cell sequencing microfluidic technologies for molecular diagnostics applications
  • Sequanta Technologies, a multiomics company committed to building DNA, RNA, epitome, and proteomics technology platforms for research and clinical applications

Representatives from Mobidrop Biotechnology, Sequanta Technologies, and Illumina.
Entrepreneurs from two startups selected for the inaugural funding cycle of the Sequoia Capital China Intelligent Healthcare Genomics Incubator and a representative of Illumina for Startups China.

Illumina's genomics incubator initiative, Illumina for Startups, is intended to create an innovative ecosystem for the genomics industry by partnering venture capital investors with entrepreneurs to create, launch, and grow genomics startups, Illumina said.

So far this year, Illumina has invested in 61 genomics startups across the globe, which have collectively raised over $1 billion in venture capital funding, the company said. Applications for the second funding cycle are open until March 1, 2022.

Illumina for Startups pushes boundaries of genomics by supporting early-stage companies
Most scientists are familiar with the genomics giant Illumina, which is known for its DNA sequencing technologies. However, Illumina has an accelerator...
Illumina Ventures raises $325M to fund health startups
Illumina Ventures has raised $325 million for its second investment fund, which will support healthcare startups.
Illumina Accelerator invests in 9 genomics startups
Illumina picked nine genomics companies to join the second global funding cycle of the Illumina Accelerator in the U.S. and U.K.
Illumina launches genomics incubator in China
Illumina has partnered with investment firm Sequoia Capital China to launch a new collaboration designed to create an incubator for startup companies...

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter